Tag: venous thromboembolism
Mechanical thrombectomy shifts the needle toward interventional management of PE and...
This advertorial is sponsored by Inari Medical.
Evaluating the current standard of care for the management of acute pulmonary embolism (PE) and deep vein thrombosis...
Research suggests potential link between strenuous physical activity and increased VTE...
Published in the Journal of Thrombosis and Thrombolysis, new research with a follow-up of 27 years has found an association between high levels of...
Study reveals improved COVID-19-associated VTE outcomes in post-vaccine period
A recent study published in the Journal of Thrombosis and Thrombolysis has revealed a significant decrease in the incidence of mortality and major bleeding in...
INSIGHTS-SVT study highlights importance of individual treatment strategies
A recent study published in the Journal of Vascular Surgery: Venous and Lymphatic Disorders looked at varicose vein surgery after acute isolated superficial vein...
Manj Gohel
“As I learned more about venous pathologies, it became abundantly clear that patients with venous disease were a largely neglected population in need of...
Innova Vascular announces successful early commercial use of Laguna thrombectomy system...
Innova Vascular has announced successful early commercial use of the company's Laguna thrombectomy system. Physicians at UCLA Medical Center in Los Angeles, USA, and...
The pulmonary arterial tree—it is time we branch out
Nicolas J Mouawad (McLaren Health System, Bay City, USA) urges vascular surgeons to “get out of their comfort zone” and become more involved in...
Child-bearing age “should not be a contraindication to venous stenting”
In a recently published study, dedicated venous stents performed well through pregnancy and postpartum, and a protocol including the use of low-dose antiplatelets in...
Study finds similar rates of VTE in both flying and non-flying...
Uncertainty underlying the magnitude of risk posed by long distance air travel in venous thromboembolism (VTE) patients has created the need for a deeper,...
Risk assessment models “no better than coin toss” for predicting bleeding...
A study of two risk assessment models (RAMs) for predicting the bleeding risk in patients considered for pharmacologic prophylaxis to prevent venous thromboembolism (VTE)...
Inari Medical announces commercial launch of RevCore and Triever16 Curve for...
Inari Medical today announced the launch of two new purpose-built products, the RevCore thrombectomy catheter, and the Triever16 Curve catheter.
According to a company press...
Akura Medical announces successful first-in-human use of its mechanical thrombectomy platform
Akura Medical announced today it has initiated its first-in-human clinical study of the Akura mechanical thrombectomy platform. A press release notes that the Akura...
New study demonstrates IVC filters “safe and effective” in treating venous...
Few adverse events are connected to the use of inferior vena cava (IVC) filters to help prevent deep vein blood clots from developing into...
Inari Medical announces first patient enrolment in DEFIANCE trial of the...
Inari Medical has announced that the first patient has been enrolled in DEFIANCE, a prospective randomised controlled trial (RCT) comparing the clinical outcomes of...
Real-world analysis confirms benefit of Xarelto in treating CAT as apixaban
Head-to-head observational analysis showed Xarelto as effective in treating cancer-associated thromboembolism (CAT) as apixaban.
The Janssen Pharmaceutical Companies of Johnson & Johnson have announced observational...
Experts establish international standard set of outcome measures for patients with...
The International Consortium for Health Outcomes Measurement (ICHOM) venous thromboembolism (VTE) working group has developed a standard set of outcome measures for patients with...
Key differences in presentation, outcomes for distal versus proximal DVT uncovered
A new study highlights key differences in clinical features and comorbidities, as well as short-term and also long-term outcomes for patients with distal deep...
Compression duration affects pain following superficial venous intervention, study finds
Postprocedural compression of one to two weeks after superficial venous incompetence (SVI) treatment is associated with reduced pain compared with a shorter duration. This...
Inari Medical announces leadership succession plan
This week Inari Medical announced that chief operating officer Drew Hykes will succeed Bill Hoffman as chief executive officer, effective 1 January 2023. Hykes...
Michael Cerminaro to succeed Marvin Woodall as CEO of Thrombolex
Thrombolex has announced that its board of directors has named Michael Cerminaro chief executive officer (CEO) effective 13 July 2022, the date of the...
VTE: Fewer recurrences with low-dose apixaban compared to discontinuation of the...
Patients who have suffered from a first episode of unprovoked venous thromboembolism (VTE) have an eight times higher risk of recurrence if they stop...
Cordis makes strategic investment in E2, a developer of next-generation thrombectomy...
Cordis has announced a strategic investment venture that will expand the scope of the global cardiovascular technology company into the venous thromboembolism (VTE) market...
Prolonged TV watching may increase risk of venous thromboembolism
A new study reports that watching TV for four hours a day or more is associated with a 35% higher risk of venous thromboembolism...
FDA approves two paediatric venous thromboembolism indications for Janssen’s Xarelto
The Janssen Pharmaceutical Companies of Johnson & Johnson recently announced that the US Food and Drug Administration (FDA) has approved two paediatric indications for...
Thromboprophylaxis with anticoagulants “likely effective” at preventing VTE post-vascular surgery, larger...
“Among patients undergoing vascular surgery, thromboprophylaxis with anticoagulants showed a trend towards reduced incidence of VTE when compared to placebo,” Tarek Haykal (Duke...
Adjunctive compression to standard prophylaxis for postoperative VTE shows benefit in...
Among patients with a Caprini score of ≥11 who received standard prophylaxis for venous thromboembolism (VTE), adjunctive intermittent pneumatic compression (IPC) resulted in a...
Mayo Clinic study provides clarity on use of anticoagulants to treat...
A study by Mayo Clinic researchers provides some clarity on the use of direct oral anticoagulants (DOACs), such as apixaban and rivaroxaban, to treat...
Study launched to assess blood clot prediction model for paediatric patients
Monroe Carell Jr Children's Hospital at Vanderbilt (Nashville, USA) has launched a study to determine the impact of a predictive model for identifying paediatric...
Recent advances in VTE management provide much-needed clarity, but more needs...
Manjit Gohel (Cambridge, UK) and Stephen Black (London, UK) write that several recent advances in the management of venous thromboembolism (VTE) have provided clarity...
Further research will soon generate standardised approach to VTE in COVID-19...
At VENOUS2021 (17–20 March, virtual), the annual meeting of the American Venous Forum, Geno Merli (Thomas Jefferson University Hospital, Philadelphia, USA) gave a keynote...
Interview: Comprehensive, patient-friendly risk assessment “crucial” to VTE prevention
From the first research linking heparin to a reduction in fatal pulmonary embolism (PE), to the development and refinement of risk assessment tools to...
Marathon Medical wins inclusion of the Geko device on its Veterans...
Sky Medical Technology has announced the inclusion of its flagship product, the Geko device, on a US Veterans Health Administration (VA) Federal Supply Schedule...
High thrombotic risk in cancer patients receiving immunotherapy
According to a recent study, patients with cancer under immune checkpoint inhibitor therapy are at high risk of thromboembolism, especially venous thromboembolism (VTE). Furthermore,...
Meta-analysis: IVC filters should be considered for certain patients at high...
In a recent meta-analysis, Yang Liu, Huan Lu (Henan Cancer Hospital, Zhengzhou, China), and colleagues found insufficient evidence to prove that inferior vena cava...
DIVERSITY trial finds adjusted dabigatran dosing algorithm appropriate for treatment of...
In a recent randomised controlled trial, an age-adjusted, weight-adjusted dabigatran dosing algorithm was found to be appropriate in children under 18 years old with...
VTE-related factors and elevated bleeding risk associated with IVC filter placement...
In a recent study, factors related with venous thromboembolism (VTE) severity—including pulmonary embolism response team (PERT) referral from the intensive care unit (ICU) and...
Comparable risk of recurrent VTE between patients with unprovoked VTE and...
Patients with venous thromboembolism (VTE) carry a high risk of recurrence. Accordingly, a 16-year Danish prospective cohort study of nearly 74,000 patients with incident VTE...
Society of Interventional Radiology publishes IVC filter guidelines
The Society of Interventional Radiology (SIR) recently published new clinical practice guidelines that provide evidence-based recommendations on the use of inferior vena cava (IVC)...
DOACs show promise over heparin injections in meta-analysis comparing cancer-associated VTE...
A recent meta-analysis found that direct oral anticoagulants (DOACs) appear to be a “reasonable alternative” to low molecular weight heparin (LMWH) for the treatment...
COVID-19 associated VTE: International thrombosis community urge WHO to act
The International Society on Thrombosis and Haemostasis (ISTH), on behalf of the international thrombosis community, have called on the World Health Organisation (WHO) to...
Study reports low rates of bleeding and VTE after 12 months...
Daiichi Sankyo Europe GmbH has announced results from five analyses of 12-month data from ETNA-VTE (Edoxaban treatment in routine clinical practice in patients with...
AHA and ISTH release joint statement on future VTE research priorities
The International Society on Thrombosis and Haemostasis (ISTH) and the American Heart Association (AHA) have released a joint scientific statement identifying the top five priorities for...
American Heart Association issues call to action to prevent VTE in...
Venous thromboembolism (VTE) is the leading cause of preventable hospital death in the USA and worldwide. A new policy statement by the American Heart...
Geko device represents an alternative to IPC devices during COVID-19
Sky Medical Technology highlights a publication on 5 May 2020 in the Journal of Thrombosis and Haemostasis showing the incidence of venous thromboembolism (VTE) in...
Compression stockings might not be needed to prevent blood clots after...
Compression stockings might be unnecessary to prevent blood clots in most patients undergoing non-emergency (elective) surgery, finds a clinical trial published by The BMJ...
New study addresses thromboembolic complications in COVID-19 patients
There is an “urgent need” to improve specific venous thromboembolism (VTE) diagnostic strategies and investigate the efficacy and safety of thromboprophylaxis in ambulatory COVID-19...
AVF releases white paper on considerations in prophylaxis and treatment of...
The COVID-19 subcommittee of the American Venous Forum (AVF) has issued a white paper on considerations in prophylaxis and treatment of venous thromboembolism (VTE)...
Updated VTE treatment guideline for patients with cancer revealed by ASCO
An updated guideline on the prophylaxis and treatment of venous thromboembolism (VTE) in patients with cancer has been unveiled by the American Society of...
Paediatric trial finds rivaroxaban similar to standard anticoagulation in treatment of...
The Janssen Pharmaceutical Companies of Johnson & Johnson announced today new results from the Phase 3 EINSTEIN-Jr study, showing paediatric patients (aged birth to...
Increased risk of VTE found in critically ill H1N1 patients with...
A new study has found that intensive care unit patients with swine flu (H1N1) and acute respiratory distress syndrome (ARDS) were 33 times more...
Study finds significant association between low bilirubin levels and venous thromboembolism
A recent paper published by Hakan Duman (Recep Tayyip Erdoğan University, Rize, Turkey) and colleagues in the Journal of Vascular Surgery: Venous and Lymphatic...
BTG acquires Novate Medical
BTG has announced it has acquired Novate Medical, a medical device company focused on the prevention of pulmonary embolism in patients at high risk...
Cancer-associated VTE trial sees “lower rate of recurrent VTE with edoxaban...
Daiichi Sanyoko has announced the results from their Hokusai-VTE CANCER trial evaluating the direct oral anticoagulant edoxaban for treatment of venous thromboembolism (VTE) in...
Inari Medical announces completion of enrolment in the FLARE study for...
Inari Medical has announced that it has completed enrolment of its investigational device exemption (IDE) study. The FlowTriever Pulmonary Embolectomy Clinical Study (FLARE) study...
More evidence that statins could prevent blood clots in the veins
Further evidence has been found by researchers at the UK’s University of Leicester and University of Bristol to suggest statins could "significantly reduce" the...
Canadian study finds rivaroxaban more effective at preventing recurrent blood clots...
A Canadian-led international research team has found that the blood thinner rivaroxaban is as safe as aspirin, and more effective at preventing recurrence of...
Use of computerised systems may help identify patients at decreased risk...
The use of computerised clinical decision support systems among surgical patients are associated with a significant increase in the proportion of patients with adequately...
First patient enrolled in Daiichi Sankyo European edoxaban registry
The first patient has been enrolled in Daiichi Sankyo’s EMIT-AF/VTE (Edoxaban Management in Diagnostic and Therapeutic Procedures) study. This registry will collect real-world clinical...